| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| MYC |
liver |
Genotype: R26-rtTA, tet-YAP |
Permissive
|
Mus musculus |
GSE83863
...
|
MA0059.1
...
|
| MYC |
liver |
Genotype: R26-rtTA, tet-YAP, tet-Myc |
Permissive
|
Mus musculus |
GSE83863
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
Treatment: 400nM 4-hydroxytamoxifen Cell type: immortalized embryonic fibroblasts Genotype: 3T9MycER |
Permissive
Robust
|
Mus musculus |
GSE83866
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
Time: 0 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 |
Permissive
Robust
|
Mus musculus |
GSE98419
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
Time: 10 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 |
Permissive
Robust
|
Mus musculus |
GSE98419
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
Time: 20 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 |
Permissive
Robust
|
Mus musculus |
GSE98419
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
Time: 30 min Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 |
Permissive
Robust
|
Mus musculus |
GSE98419
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
Time: 2hrs Treatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 |
Permissive
Robust
|
Mus musculus |
GSE98419
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
Time: 4 hrsTreatment: infected with MycER, MycER activation was achieved by addition of 400nM of the synthetic 4-hydroxytamoxifen (OHT; Sigma-Aldrich) Genotype: c-myc flox/flox (c-myc knockout) Source: embryonic fibroblasts, E13.5 |
Permissive
Robust
|
Mus musculus |
GSE98419
...
|
MA0059.1
...
|
| MYC |
Tet21N (neuroblastoma) |
Treatment: 1ug/mL doxycycline for 7 days prior to harvest Genotype: wildtype MYC Passage: 10 -15 Cell type: neuroblastoma cell line |
Permissive
Robust
|
Homo sapiens |
GSE117406
...
|
MA0059.1
...
|
Showing 10 records in page 10
from 23 pages